期刊文献+

人内皮抑素与IL_3信号肽融合蛋白真核表达载体的构建 被引量:8

Construction of the eukaryotic expression vector expressing the fusion protein of human endostatin protein and IL_3 signal peptide
下载PDF
导出
摘要 目的构建IL_3信号肽与内皮抑素融合蛋白基因的真核表达载体。方法用PCR方法扩增IL_3信号肽序列和人内皮抑素基因,然后采用重叠延伸PCR拼接的方法将两者拼接和扩增。并将IL_3-endocl)NA克隆到真核表达载体pcDNA3.1(+)中。结果 IL_3-endo融合蛋白基因包括了IL_3信号肽序列和人内皮抑素蛋白全长基因,基因总长度约701bp,被正确拼接,并克隆到pcDNA3.1(+)的CMV启动子下游。序列分析证实克隆序列、插入方向和读码框架均正确。结论成功的将IL_3信号肽序列连接到人内皮抑素基因序列前并构建了其真核表达载体,为以后的内皮抑素用于基因治疗打下了基础。 AIM To construct the eukaryotic expression vector which expresses the fusion protein of IL_3 signal peptide and human endostatin (endo)protein. METHODS IL_3 signal sequence and human endostatin gene were amplified with PCR and spliced with overlap extension PCR. The IL_3-endo cDNA was cloned into mammalian expression vector pcDNA3.1 (+). RESULTS The chimeric gene, about 701bp, which included IL_3 signal sequence and entire human endostatin gene, was successfully spliced and cloned into eukaryotic expression vector pcDNA3.1 (+) downstream from the CMV promoter. The data of nucleotide sequence determination showed that the chimeric cDNA sequence was the same as reported sequence, and in one ORF. CONCLUSION The recombinant vector containing chimeric gene of IL_3-endostatin can express IL_3-endostatin protein in mammalian cell and secrete to extracellular matrix from cells. The success of constructing this vector laid the foundation for studying tumor gene therapy by endostatin.
出处 《世界华人消化杂志》 CAS 2001年第1期43-46,共4页 World Chinese Journal of Digestology
基金 国家自然科学基金 No.39970819
关键词 信号肽类 内皮抑素 基因疗法 真核表达载体 聚合酶链反应 基因扩增 signal peptides endostatin gene therapy eukaryotic expression vector polymerase chain reaction gene amplification
  • 相关文献

参考文献6

二级参考文献47

  • 1王秀萍,郭政.降钙素基因相关肽与疼痛和免疫炎症反应[J].山西医药杂志,2005,34(6):481-483. 被引量:10
  • 2吴中欣,唐跃明,韩启德,王宪.炎症介质对离体大鼠肠系膜动脉降钙素基因相关肽释放的影响[J].生理学报,1996,48(6):571-576. 被引量:5
  • 3朱汉章.针刀医学概述[J].科学之友,2007(04B):5-17. 被引量:21
  • 4萨姆布鲁克J 费里奇EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1993.474-489. 被引量:25
  • 5Wizigmann-Voos S,Breier G,Risau W,et al.Up-regulation of vascular endothelial growth factor and its receptors in von HippelLindau disease-associated and sporadic hemangioblastomas. Cancer Research . 1995 被引量:1
  • 6Plate KH,Breier G,Weich HA,et al.Vascular endothelial growth factor is a potential tumor angiogenesis factor in human glioma in vivo. Nature . 1992 被引量:1
  • 7Connoily DT,Heiveman DM,Nelson R, et al.Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. . 1989 被引量:1
  • 8Asano M,Suzuki H,Kondo S et al.Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor vascular petmeability factor 121 (VEGF VPF 121). Hybridoma . 1995 被引量:1
  • 9Kim KJ,Li B,Winner J,et al.Inhibition of vascular endothelial growth factorinduced angiogenesiss uppresses tumor growth invivo. The Nation . 1993 被引量:1
  • 10Brown LF,Berse B,Jackman RW,Tognazzi K,Manseau EJ,Senger DR,Dvorak HF.Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Research . 1993 被引量:1

共引文献89

同被引文献51

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部